Paglalarawan

A rare disease, also referred to as an orphan disease, is any disease that affects a small percentage of the population. There are thousands of rare diseases. To date, six to seven thousand rare diseases have been discovered and new diseases are regularly described in medical literature. The global rare disease diagnostics market in terms of revenue is set to grow by US$ 12 billion during 2021-2027, growing at a compound annual growth rate (CAGR) ng mga 8.6% sa panahon ng pagtataya, ayon sa data at analytics company na StrategyHelix. Rising burden of diseases and increase in incidence and prevalence of genetic disorders and various types of cancer, increase in adoption of whole genome and exome sequencing, and increasing research funding and surge in usage for new techniques are driving market growth.

Ang ulat ay nagbibigay ng napapanahong data ng laki ng merkado para sa panahon 2017-2020 at forecast na 2027 covering key market aspects like sales value for rare disease diagnostics. The global rare disease diagnostics market is segmented on the basis of disease, technology, age, analysis target, and region. By disease, it is categorized into cardiovascular, central nervous system, endocrine and metabolic, hematology, immune and inflammation, rare cancers, and other diseases. The diagnostics for rare cancers segment held the largest market share in 2020. By technology, the rare disease diagnostics market is divided into polymerase chain reaction (PCR), next-generation sequencing, microarrays, at iba pa. Based on age, the rare disease diagnostics market is divided into children, and adult. Rare disease diagnostics market by analysis target is divided into multiple genes, whole exome, single genes, and whole genome.

The report has profiled some of the key players of the market such as 3billion Inc., Agilent Technologies Inc., BGI Group, Centogene AG, Eurofins Scientific SE, Illumina Inc., Invitae Corporation, Laboratory Corporation of America Holdings, PerkinElmer Inc., Quest Diagnostics Incorporated.

Ang ulat ay isang napakahalagang mapagkukunan para sa mga kumpanya at organisasyon na aktibo sa industriyang ito. It provides a cohesive picture of the rare disease diagnostics market to help drive informed decision making for industry executives, mga gumagawa ng patakaran, akademiko, at mga analyst.

Saklaw ng Ulat

Disease: cardiovascular, central nervous system, endocrine and metabolic, hematology, immune and inflammation, rare cancers, and other diseases
Technology: polymerase chain reaction (PCR), next-generation sequencing, microarrays, at iba pa
Age: children, and adult
Rehiyon: Hilagang Amerika, Asya Pasipiko, Europa, and Rest of the World (ROW)
Analysis target: multiple genes, whole exome, single genes, and whole genome
Mga Taon na Itinuturing: Ang ulat na ito ay sumasaklaw sa panahon 2017 sa 2027

Mga Pangunahing Benepisyo para sa mga Stakeholder

Get a comprehensive picture of the global rare disease diagnostics market
Identify regional strategies and strategic priorities on the basis of local data and analysis
Pinpoint ang mga sektor ng paglago at mga trend para sa pamumuhunan
Understand what the future of the global rare disease diagnostics market looks like
Kilalanin ang mapagkumpitensya na landscape at window ng pagkakataon

Talaan ng mga Nilalaman

1. Kahulugan ng Market
2. Metodolohiya ng Pananaliksik
3. Market Data & Outlook
3.1 Halaga ng Market
3.2 Pagtataya ng Halaga sa Market
4. Rare Disease Diagnostics Market by Disease
4.1 Cardiovascular
4.2 Central Nervous System
4.3 Endocrine And Metabolic
4.4 Hematology
4.5 Immune And Inflammation
4.6 Rare Cancers
4.7 Other Diseases
5. Rare Disease Diagnostics Market by Technology
5.1 Polymerase Chain Reaction (Pcr)
5.2 Next-Generation Sequencing
5.3 Microarrays
5.4 Ang iba naman
6. Rare Disease Diagnostics Market by Age
6.1 Children
6.2 Adult
7. Rare Disease Diagnostics Market by Analysis Target
7.1 Multiple Genes
7.2 Whole Exome
7.3 Single Genes
7.4 Whole Genome
8. Rare Disease Diagnostics Market by Region
8.1 Hilagang Amerika
8.2 Asya Pasipiko
8.3 Europa
8.4 Rest Of The World (Row)
9. Mga Profile ng Kumpanya
9.1 3billion Inc.
9.2 Agilent Technologies Inc.
9.3 BGI Group
9.4 Centogene AG
9.5 Eurofins Scientific SE
9.6 Illumina Inc.
9.7 Invitae Corporation
9.8 Laboratory Corporation of America Holdings
9.9 PerkinElmer, Inc.
9.10 Quest Diagnostics Incorporated
10. Apendiks
10.1 Tungkol sa StrategyHelix
10.2 Pagtanggi